🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

RecruitingPhase 4Ages any - anyAllSwedish Orphan Biovitrum
NCT07746895 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to evaluate the effectiveness and safety of Pegcetacoplan in patients with C3G and primary IC-MPGN in the real-world setting. This study will also assess biomarkers not routinely measured in clinical practice. Results will support the long-term evaluation of the benefit-risk profile of pegcetacoplan in a broad patient population, informing clinical decision-making.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Have received or plan to receive pegcetacoplan for the treatment of C3G or primary IC-MPGN. * Provided signed and dated informed consent. For participants under the legal age signed and dated informed consent is provided by the participant's legally authorised representative. Assent will also be obtained from paediatric participants as required by local regulations. Exclusion Criteria: * Receiving an investigational treatment for C3G or primary IC-MPGN at the time of pegcetacoplan initiation. * Initiated treatment with pegcetacoplan in an interventional study.
💊

What it tests

  • Pegcetacoplan
📍

Where

101 sites
Nepean Hospital
Kingswood, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Medizinische Universität Graz
Graz, Austria
Uniklinik Innsbruck
Innsbruck, Austria
Allgemeines Krankenhaus Wien Universitätsklinik
Vienna, Austria
Klinik Ottakring
Vienna, Austria
Cliniques Universitaires Saint-Luc
Brussels, Belgium
University hosptial of Antwerpen
Edegem, Belgium

…and 93 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy